Kinase Inhibitors And Methods Of Use Thereof
AssigneeArray BioPharma Inc.
InventorsRobert Groneberg, Laurence E. Burgess, Darren Harvey, Ellen Laird, Mark C. Munson, James P. Rizzi, Martha Rodriguez, Charles Todd Eary, Daniel John Watson
Life of this patent
Estimating the term…
Abstract
The compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof are useful in the treatment and prevention of various disorders mediated by kinases.
Claims22
The compound having the Formula I:
- or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
A compound of formula II
- or a salt thereof, in which P1 represents a hydrogen atom or a hydroxyl protecting group.
A compound of formula IV
- wherein Re represents a hydrogen atom or a residue of an alcohol.
(canceled)
(canceled)
(canceled)
2-(5-(2-((3-(3-Tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)methyl)-4-fluorophenoxy)-1H-indazol-1-yl)ethyl dihydrogenphosphate, or a pharmaceutically acceptable salt thereof.
(canceled)
Dependencies are inferred from the claim text.